Concepedia
Statistics
Publications
6
Citations
565
H-Index
Active since
2013
Affiliations
Inserm(Current)
Université Toulouse III - Paul Sabatier
Centre de Recherches en Cancérologie de Toulouse
Centre National de la Recherche Scientifique
Institut universitaire du cancer de Toulouse Oncopole
David Garandeau is an author at Inserm specializing in oncology, cell signaling, and cell biology.
Publications per year
2013–2021
Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
Victor Laurent, Adrien Guérard, Catherine Mazerolles et al. · Nature Communications · 2016 · 288 citations · Full text
Medicine, Cancer Biology, Oncology +17
Periprostatic Adipose Tissue Favors Prostate Cancer Cell Invasion in an Obesity-Dependent Manner: Role of Oxidative Stress
Victor Laurent, Aurélie Toulet, Camille Attané et al. · Molecular Cancer Research · 2019 · 116 citations · Full text
Life Sciences, Cell Biology, Oncology +17
Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy
David A. Dyment, Erick Sell, Megan R. Vanstone et al. · Clinical Genetics · 2013 · 52 citations
Life Sciences, Genetics, Neurology +17
Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells
J. C. Leclerc, David Garandeau, Charlotte Pandiani et al. · Oncogene · 2018 · 43 citations
Medicine, Cell Biology, Oncology +16
Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas
David Garandeau, Justine Noujarède, J. C. Leclerc et al. · Molecular Cancer Therapeutics · 2018 · 36 citations
Medicine, Oncology, Pharmacology +15
1–5 of 6